In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia

Peptides

Volumn 30, Issue 9, 2009, Pages 1622-1626

  Maisetta, Giuseppantonio ^a   Mangoni, Maria Luisa ^b   Esin, Semih ^a   Pichierri, Giuseppe ^a   Capria, Anna Lisa ^a   Brancatisano, Franca Lisa ^a   Di Luca, Mariagrazia ^a   Barnini, Simona ^a   Barra, Donatella ^b   Campa, Mario ^a   Batoni, Giovanna ^a  

^a UNIVERSITY OF PISA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antimicrobial peptides; Esculentin; Stenotrophomonas maltophilia; Synergism

Indexed keywords

AMIKACIN; CEFTAZIDIME; COLISTIN; COTRIMOXAZOLE; ESCULENTIN[1-18]; LEVOFLOXACIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; FROG; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

AMIKACIN; AMPHIBIAN PROTEINS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CEFTAZIDIME; COLISTIN; DRUG SYNERGISM; HUMANS; KINETICS; MICROBIAL VIABILITY; OFLOXACIN; PEPTIDE FRAGMENTS; RANA ESCULENTA; SERUM; STENOTROPHOMONAS MALTOPHILIA;

ANURA; BACTERIA (MICROORGANISMS); STENOTROPHOMONAS MALTOPHILIA;

EID: 67849101636     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.06.004     Document Type: Article

References (28)

1. Cassone M., Vogiatzi P., La Montagna R., De Olivier Inacio V., Cudic P., Wade J.D., et al. Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics. Peptides 29 (2008) 1878-1886
2. Cirioni O., Giacometti A., Silvestri C., Della Vittoria A., Licci A., Riva A., et al. In vitro activities of tritripticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. Antimicrob Agents Chemother 50 (2006) 3923-3925
3. Cirioni O., Giacometti A., Ghiselli R., Kamysz W., Orlando F., Moccheggiani F., et al. Citropin 1.1-treated central venous catheters improve the efficacy of the hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides 27 (2005) 1210-1216
4. Conlon J.M., Kolodziejek J., and Nowotny N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim Biophys Acta 169 (2004) 1-14
5. Conlon J.M. Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae. Peptides 29 (2008) 1815-1819
6. Denton M., and Kerr K.G. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11 (1998) 75-80
7. Eliopoulos G.M., and Moellering R.C. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1996), Williams and Wilkins, Baltimore, MD, USA 330-396
8. Falagas M.E., and Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-rsistant Gram-negative bacterial infections. Clin Infect Dis 40 (2005) 1333-1341
9. Fritsche T.R., Rhomberg P.R., Sader H.S., and Jones R.N. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. J Antimicrob Chemother 61 (2008) 1092-1098
10. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 (2001) S104-S113
11. Giacometti A., Cirioni O., Komysz W., D'Amato G., Silvestri C., Del Prete M.S., et al. In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob Agents Chemother 49 (2005) 1249-1252
12. Hancock R.E., and Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 16 (1998) 82-88
13. Herman T. Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci 64 (2007) 1841-1852
14. Koczulla A.R., and Bals R. Antimicrobial peptides: current status and therapeutic potential. Drugs 63 (2003) 389-406
15. Maisetta G., Batoni G., Esin S., Luperini F., Pardini M., Bottai D., et al. Activity of human beta defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob Agents Chemother 47 (2003) 3349-3351
16. Maisetta G., Di Luca M., Esin S., Florio W., Brancatisano F.L., Bottai D., et al. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29 (2008) 1-6
17. Mangoni M.L., Fiocco D., Mignogna G., Barra D., and Simmaco M. Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta. Peptides 24 (2003) 1771-1777
18. Mangoni M.L., Maisetta G., Di Luca M., Gaddi L.M., Esin S., Florio W., et al. Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother 52 (2008) 85-91
19. Nicodemo A.C., and Garcia Paez J.I. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Microbiol Infect Dis 26 (2007) 229-237
20. Nicolas P., and Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu Rev Microbiol 49 (1995) 277-304
21. Odds F.C. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52 (2003) 1
22. Peschel A., and Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4 (2006) 529-536
23. Sader H.S., and Jones R.N. Antimicrobial susceptibility of uncommonly isolated non enteric Gram-negative bacilli. Int J Antimicrob Agents 25 (2005) 95-109
24. Safdar A., and Rolston K.V. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45 (2007) 1602-1609
25. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 66 (2002) 236-248
26. Simmaco M., Mignogna G., Barra D., and Bossa F. Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J Biol Chem 269 (1994) 11956-11961
27. Svendsen J.S., Brandsdal B.O., Stensen W., and Svendsen J.B. Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect. J Med Chem 50 (2007) 3334-3339
28. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395